Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Well, show me a Micro-Pharma that will present Significant data from their COVID CT on 'Time off ventilator, time in Intensive care, O2 levels and IL-6', to the FDA at their EOP2 meeting in the near future.

Can AGN get approved Endpoints for these indications in a Phase 3 CT.
How can the Ifenprodil CC/IPF CT be changed/incorporated/related to the Covid CT in the future?
The accommodating new Guidelines from the FDA seem encouraging, IMO...

A Glass of Wine and Best Wishes...GLTA...